The antimalarial pipeline
- 1 October 2018
- journal article
- research article
- Published by Elsevier BV in Current Opinion in Pharmacology
- Vol. 42, 1-6
- https://doi.org/10.1016/j.coph.2018.05.006
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trialThe Lancet Infectious Diseases, 2015
- Efficacy and Safety of the Mosquitocidal Drug Ivermectin to Prevent Malaria Transmission After Treatment: A Double-Blind, Randomized, Clinical TrialClinical Infectious Diseases, 2014
- Origins of the specificity of inhibitor P218 toward wild-type and mutantPfDHFR: a molecular dynamics analysisJournal of Biomolecular Structure and Dynamics, 2014
- Introducing the concept of a new pre-referral treatment for severely ill febrile children at community level: a sociological approach in Guinea-BissauMalaria Journal, 2014
- Designing the next generation of medicines for malaria control and eradicationMalaria Journal, 2013
- Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trialThe Lancet, 2010
- Amodiaquine Resistance in Plasmodium falciparum Malaria in Afghanistan Is Associated with the pfcrt SVMNT Allele at Codons 72 to 76Antimicrobial Agents and Chemotherapy, 2010
- Evidence of Artemisinin-Resistant Malaria in Western CambodiaThe New England Journal of Medicine, 2008
- Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trialThe Lancet, 2005
- Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy numberThe Lancet, 2004